Clinical and Molecular Characteristics of Histiocytic Disorders
Mayo Clinic
Summary
This study is being done to collect medical and personal histories as well as a samples of blood, other body fluid and/or tumor/disease tissue for current and future research studies on histiocytic disorders.
Description
PRIMARY OBJECTIVES: I. Define molecular signature and genomic landscape of histiocytic disorders. II. Correlate genomic findings with transcriptional abnormalities. III. Identify promising prognostic alterations and potential therapeutic targets. OUTLINE: This is an observational study. Patients complete questionnaires and undergo blood and tissue sample collection. Patients' medical records are also reviewed.
Eligibility
- Age range
- 1+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: * \* All patients diagnosed with histiocytic disorders and age ≥1 year Exclusion Criteria: * \* \< 1 years age
Interventions
- OtherNon-Interventional Study
Non-interventional study
Location
- Mayo Clinic in RochesterRochester, Minnesota